AAV-delivered miR-29 (Johns Hopkins University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAAV-delivered miR-29 (Johns Hopkins University)
Drug Alias NameAdenovirus associated virus-delivered miR-29 (Johns Hopkins University)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins Technology VenturesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsFibrosis

Other Information

ATC CodeN/A
Related LinksN/A